{"id":"https://openalex.org/W4361906357","doi":"https://doi.org/10.1158/1078-0432.22448462","title":"Supplementary Methods, Figure Legends from COX-2\u2013Independent Effects of Celecoxib Sensitize Lymphoma B Cells to TRAIL-Mediated Apoptosis","display_name":"Supplementary Methods, Figure Legends from COX-2\u2013Independent Effects of Celecoxib Sensitize Lymphoma B Cells to TRAIL-Mediated Apoptosis","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361906357","doi":"https://doi.org/10.1158/1078-0432.22448462"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22448462","doi":"https://doi.org/10.1158/1078-0432.22448462","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22448462","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legends_from_COX-2_Independent_Effects_of_Celecoxib_Sensitize_Lymphoma_B_Cells_to_TRAIL-Mediated_Apoptosis/22448462/1/files/39899510.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legends_from_COX-2_Independent_Effects_of_Celecoxib_Sensitize_Lymphoma_B_Cells_to_TRAIL-Mediated_Apoptosis/22448462/1/files/39899510.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006966237","display_name":"Anne-Sophie Gallou\u00ebt","orcid":"https://orcid.org/0000-0001-5815-3454","observed_orcids":["https://orcid.org/0000-0001-5815-3454"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne-Sophie Gallouet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034242712","display_name":"Marion Travert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marion Travert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073836179","display_name":"Laurence Bresson\u2010Bepoldin","orcid":"https://orcid.org/0000-0002-8829-9945","observed_orcids":["https://orcid.org/0000-0002-8829-9945"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laurence Bresson-Bepoldin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025697008","display_name":"Fabien Guilloton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fabien Guilloton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013773514","display_name":"C\u00e9line Pangault","orcid":"https://orcid.org/0000-0003-3978-2209","observed_orcids":["https://orcid.org/0000-0003-3978-2209"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C\u00e9line Pangault","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025724403","display_name":"Sylvie Caulet-Maugendre","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sylvie Caulet-Maugendre","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045374333","display_name":"Thierry Lamy","orcid":"https://orcid.org/0000-0003-2960-4855","observed_orcids":["https://orcid.org/0000-0003-2960-4855"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thierry Lamy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015523345","display_name":"Karin Tarte","orcid":"https://orcid.org/0000-0002-6809-917X","observed_orcids":["https://orcid.org/0000-0002-6809-917X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karin Tarte","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5044955159","display_name":"Thierry Guillaudeux","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thierry Guillaudeux","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9320999979972839,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9320999979972839,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.04820000007748604,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.9739999771118164},{"id":"https://openalex.org/keywords/trail","display_name":"TRAIL","score":0.9739999771118164},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9020000100135803},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.902999997138977},{"id":"https://openalex.org/keywords/b-cells","display_name":"B cells","score":0.9879999756813049},{"id":"https://openalex.org/keywords/drug-sensitization","display_name":"drug sensitization","score":0.7369999885559082}],"concepts":[{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.8175121545791626},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6697167754173279},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.548311173915863},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35536038875579834},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3363170325756073},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3017420768737793},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.29276472330093384},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28598910570144653},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09012287855148315}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22448462","doi":"https://doi.org/10.1158/1078-0432.22448462","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22448462","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legends_from_COX-2_Independent_Effects_of_Celecoxib_Sensitize_Lymphoma_B_Cells_to_TRAIL-Mediated_Apoptosis/22448462/1/files/39899510.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22448462.v1","doi":"https://doi.org/10.1158/1078-0432.22448462.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22448462.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22448462","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legends_from_COX-2_Independent_Effects_of_Celecoxib_Sensitize_Lymphoma_B_Cells_to_TRAIL-Mediated_Apoptosis/22448462","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22448462","doi":"https://doi.org/10.1158/1078-0432.22448462","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22448462","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legends_from_COX-2_Independent_Effects_of_Celecoxib_Sensitize_Lymphoma_B_Cells_to_TRAIL-Mediated_Apoptosis/22448462/1/files/39899510.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.504800021648407}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W4361906357.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2105573846","https://openalex.org/W4361960971","https://openalex.org/W1976821497","https://openalex.org/W775737539","https://openalex.org/W1994761429","https://openalex.org/W2412821556","https://openalex.org/W2168820246","https://openalex.org/W1983479821","https://openalex.org/W2793848589","https://openalex.org/W2368413340"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"176K":[3]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}